Patents by Inventor Kumarapandian Paulvannan

Kumarapandian Paulvannan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Thioxothiazolidine-4-One Derivatives And Their Uses
    Publication number: 20250017910
    Abstract: Disclosed herein are 2-thioxothiazolidine-4-one derivatives, and pharmaceutical compositions thereof. The 2-thioxothiazolidine-4-one derivatives and pharmaceutical compositions thereof may be used to treat or prevent medical disorders such as, for example, Parkinson's disease, and disorders of dopamine homeostasis, such as for example, methamphetamine and cocaine addiction.
    Type: Application
    Filed: July 1, 2024
    Publication date: January 16, 2025
    Inventors: Kumarapandian Paulvannan, Dennis Solas, Anuradha F. Lingappa, Vishwanath R. Lingappa
  • Isoquinoline Derivatives, Methods of Synthesis and Uses Thereof
    Publication number: 20240300962
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.
    Type: Application
    Filed: May 13, 2024
    Publication date: September 12, 2024
    Inventors: Kumarapandian Paulvannan, Dennis Solas, Anatoliy Kitaygorodskyy, Vishwanath R. Lingappa
  • Isoquinoline derivatives, methods of synthesis and uses thereof
    Patent number: 12024521
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: July 2, 2024
    Assignee: Prosetta Biosciences, Inc.
    Inventors: Kumarapandian Paulvannan, Dennis Solas, Anatoliy Kitaygorodskyy, Vishwanath R. Lingappa
  • Host-targeted pan-respiratory antiviral small molecule therapeutics
    Patent number: 12017997
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as, for example, those caused by any viral family causing respiratory viral disease, including specifically coronaviruses and influenza viruses.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: June 25, 2024
    Assignee: Prosetta Biosciences, Inc.
    Inventors: Vishwanath R. Lingappa, Kumarapandian Paulvannan
  • Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics
    Publication number: 20240190826
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as, for example, those caused by any viral family causing respiratory viral disease, including specifically coronaviruses and influenza viruses.
    Type: Application
    Filed: December 12, 2023
    Publication date: June 13, 2024
    Inventors: Vishwanath R. Lingappa, Kumarapandian Paulvannan
  • HOST-TARGETED PAN-RESPIRATORY ANTIVIRAL SMALL MOLECULE THERAPEUTICS
    Publication number: 20230147603
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as, for example, those caused by any viral family causing respiratory viral disease, including specifically coronaviruses and influenza viruses.
    Type: Application
    Filed: October 24, 2022
    Publication date: May 11, 2023
    Inventors: Vishwanath R. Lingappa, Kumarapandian Paulvannan
  • Isoquinoline Derivatives, Methods of Synthesis and Uses Thereof
    Publication number: 20210403477
    Abstract: Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.
    Type: Application
    Filed: June 30, 2021
    Publication date: December 30, 2021
    Inventors: Kumarapandian Paulvannan, Dennis Solas, Anatoliy Kitaygorodskyy, Vishwanath R. Lingappa
  • Camptothecin derivatives and uses thereof
    Patent number: 10407437
    Abstract: Provided herein are camptothecin derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, cancer using the compounds and pharmaceutical compositions disclosed herein.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: September 10, 2019
    Assignee: Los Gatos Pharmaceuticals, Inc.
    Inventors: Peter Langecker, Matthias Steiert, Toshiaki Hino, Jan Scicinksi, Kumarapandian Paulvannan
  • Composite Nanoparticles And Uses Thereof
    Publication number: 20180369232
    Abstract: Provided herein are composite nanoparticles, methods of making composite nanoparticles and methods of using composite nanoparticles to treat or ameliorate various diseases, such as, for example, cancer.
    Type: Application
    Filed: July 3, 2018
    Publication date: December 27, 2018
    Inventors: Peter Langecker, Matthias Steiert, Toshiaki Hino, Jan Scicinski, Kumarapandian Paulvannan
  • Composite nanoparticles and uses thereof
    Patent number: 10064855
    Abstract: Provided herein are composite nanoparticles, methods of making composite nanoparticles and methods of using composite nanoparticles to treat or ameliorate various diseases, such as, for example, cancer.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: September 4, 2018
    Assignee: Los Gatos Pharmaceuticals, Inc.
    Inventors: Peter Langecker, Matthias Steiert, Toshiaki Hino, Jan Scicinksi, Kumarapandian Paulvannan
  • CAMPTOTHECIN DERIVATIVES AND USES THEREOF
    Publication number: 20170260194
    Abstract: Provided herein are camptothecin derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, cancer using the compounds and pharmaceutical compositions disclosed herein.
    Type: Application
    Filed: March 8, 2017
    Publication date: September 14, 2017
    Inventors: Peter Langecker, Matthias Steiert, Toshiaki Hino, Jan Scicinksi, Kumarapandian Paulvannan
  • COMPOSITE NANOPARTICLES AND USES THEREOF
    Publication number: 20170258785
    Abstract: Provided herein are composite nanoparticles, methods of making composite nanoparticles and methods of using composite nanoparticles to treat or ameliorate various diseases, such as, for example, cancer.
    Type: Application
    Filed: March 8, 2017
    Publication date: September 14, 2017
    Inventors: Peter Langecker, Matthias Steiert, Toshiaki Hino, Jan Scicinksi, Kumarapandian Paulvannan